NASDAQ:ZNTL | Free Cash Flow | Zentalis Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$32.96M$34,000.00-$32.99M
2025-12-31-$30.94M$0.00-$30.94M
2025-03-31-$32.64M$0.00-$32.64M
2024-12-31-$39.7M$0.00-$39.7M
2024-03-31-$51.97M$40,000.00-$52.01M-516.63%
2023-12-31-$40.6M$173,000.00-$40.77M
2023-03-31-$49.28M$0.00-$49.28M
2022-12-31-$37.33M$160,000.00-$37.49M
2022-03-31-$50.2M$450,000.00-$50.65M
2021-12-31-$37.02M$2.19M-$39.21M
2021-03-31-$37.47M$436,000.00-$37.91M
2020-12-31-$27.36M$661,000.00-$28.02M
2020-03-31-$16.87M$31,000.00-$16.9M
2019-12-31-$13.19M$36,000.00-$13.23M
2019-03-31-$9.01M$41,000.00-$9.05M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$125.25M$0.00-$125.25M
2024-12-31-$170.86M$221,000.00-$171.08M
2023-12-31-$207.82M$583,000.00-$208.41M
2022-12-31-$163.75M$2.55M-$166.3M
2021-12-31-$154.09M$6.11M-$160.2M
2020-12-31-$86.83M$758,000.00-$87.58M
2019-12-31-$39.14M$352,000.00-$39.5M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.